What chemotherapy regimen would you recommend for a patient with symptomatic cutaneous B cell lymphoma?  

Assuming that the involved area is too widespread for RT. Would you try single agent rituximab first? Or obinutuzumab? What if rituximab alone gave only a short response - would you favor RCHOP, BR, or something else?

Answer from: Medical Oncologist at Academic Institution